title: Improvement of extreme hypoxemia during end-stage congenital heart disease using nasal nitric oxide.
authors.affiliation: Department of Anesthesiology and Intensive Care, Hôpital Lariboisière, Paris, France.
authors.forename: B P
authors.initials: BP
authors.lastname: Cholley
authors.forename: U
authors.initials: U
authors.lastname: Hilbert
authors.forename: N
authors.initials: N
authors.lastname: Guinard
authors.forename: J
authors.initials: J
authors.lastname: Mateo
authors.forename: D
authors.initials: D
authors.lastname: Payen
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D005260:Female; D006330:Heart Defects, Congenital / Q000150:complications*; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy* / Q000209:etiology; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D009569:Nitric Oxide